Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Gulati

Showing results (21-30 of 154) with videos related to

Pageof 16
Sort By:
The Journal of Urology|May 22, 2019
Personalized Risks of Over Diagnosis for Screen Detected Prostate Cancer Incorporating Patient Comorbidities: Estimation and CommunicationRoman Gulati, Sarah P Psutka, Ruth Etzioni
American Journal of Epidemiology|July 1, 2016
Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population StudiesRoman Gulati, Eric J Feuer, Ruth Etzioni
European Urology|September 4, 2021
Divining Harm-Benefit Tradeoffs of Magnetic Resonance Imaging-targeted BiopsyRuth Etzioni, Michael C Haffner, Roman Gulati
The Journal of Urology|August 1, 2019
Reply by AuthorsRoman Gulati, Sarah P Psutka, Ruth Etzioni
JNCI Cancer Spectrum|October 23, 2025
Age-Specific racial disparities in the incidence of fatal prostate cancer: an analytic deconstructionMohamed Albirair, Yaw Nyame, Roman Gulati, et al.
Annals of Internal Medicine|June 5, 2013
Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screeningRuth Etzioni, Roman Gulati, Leslie Mallinger, et al.
JNCI Cancer Spectrum|October 23, 2024
Trends in age and prostate-specific antigen at prostate cancer diagnosis between 2010 and 2019Lukas Owens, Ojas Brahme, Roman Gulati, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 6, 2008
Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approachRuth Etzioni, Roman Gulati, Seth Falcon, et al.
Cancer|January 26, 2018
Racial disparities in prostate cancer survival in a screened population: Reality versus artifactDhamanpreet Kaur, Ernesto Ulloa-Pérez, Roman Gulati, et al.
Biostatistics (Oxford, England)|June 10, 2010
Calibrating disease progression models using population data: a critical precursor to policy development in cancer controlRoman Gulati, Lurdes Inoue, Jeffrey Katcher, et al.
Pageof 16

Showing results (21-30 of 154) with videos related to

Sort By:
Pageof 16
The Journal of Urology|May 22, 2019
Personalized Risks of Over Diagnosis for Screen Detected Prostate Cancer Incorporating Patient Comorbidities: Estimation and CommunicationRoman Gulati, Sarah P Psutka, Ruth Etzioni
American Journal of Epidemiology|July 1, 2016
Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population StudiesRoman Gulati, Eric J Feuer, Ruth Etzioni
European Urology|September 4, 2021
Divining Harm-Benefit Tradeoffs of Magnetic Resonance Imaging-targeted BiopsyRuth Etzioni, Michael C Haffner, Roman Gulati
The Journal of Urology|August 1, 2019
Reply by AuthorsRoman Gulati, Sarah P Psutka, Ruth Etzioni
JNCI Cancer Spectrum|October 23, 2025
Age-Specific racial disparities in the incidence of fatal prostate cancer: an analytic deconstructionMohamed Albirair, Yaw Nyame, Roman Gulati, et al.
Annals of Internal Medicine|June 5, 2013
Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screeningRuth Etzioni, Roman Gulati, Leslie Mallinger, et al.
JNCI Cancer Spectrum|October 23, 2024
Trends in age and prostate-specific antigen at prostate cancer diagnosis between 2010 and 2019Lukas Owens, Ojas Brahme, Roman Gulati, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 6, 2008
Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approachRuth Etzioni, Roman Gulati, Seth Falcon, et al.
Cancer|January 26, 2018
Racial disparities in prostate cancer survival in a screened population: Reality versus artifactDhamanpreet Kaur, Ernesto Ulloa-Pérez, Roman Gulati, et al.
Biostatistics (Oxford, England)|June 10, 2010
Calibrating disease progression models using population data: a critical precursor to policy development in cancer controlRoman Gulati, Lurdes Inoue, Jeffrey Katcher, et al.
Pageof 16